Glycopyrronium bromide
Chemical compound
Glycopyrronium bromide Trade names Robinul, Cuvposa, Seebri, others Other names glycopyrrolate (USAN US ) AHFS /Drugs.com Monograph MedlinePlus a602014 License data
Pregnancy category Routes of administration By mouth , intravenous , inhalation , topical , injection , subcutaneous Drug class Antimuscarinic agent ATC code Legal status
Elimination half-life 0.6–1.2 hours Excretion 85% Kidney, unknown amount in the bile
3-[2-Cyclopentyl(hydroxy)phenylacetoxy]-1,1-dimethylpyrrolidinium bromide
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEBI ChEMBL CompTox Dashboard (EPA ) ECHA InfoCard 100.008.990 Formula C 19 H 28 Br N O 3 Molar mass 398.341 g·mol−1 3D model (JSmol )
C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]
as cation: C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
InChI=1S/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1
Key:VPNYRYCIDCJBOM-UHFFFAOYSA-M
as cation: InChI=1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1
Key:ANGKOCUUWGHLCE-UHFFFAOYSA-N
N Y (what is this?) (verify)
Glycopyrronium bromide is a medication of the muscarinic anticholinergic group.[7] It does not cross the blood–brain barrier and consequently has few to no central effects. It is given by mouth ,[8] via intravenous injection, on the skin ,[9] and via inhalation .[4] [5] [6] It is a synthetic quaternary ammonium compound .[2] The cation , which is the active moiety , is called glycopyrronium (INN )[10] or glycopyrrolate (USAN ).
The most common side effects include irritability, flushing, blocked nose, reduced secretions in the airways, dry mouth, constipation, diarrhea, vomiting and inability to completely empty the bladder (urinary retention).[7]
In September 2012, glycopyrronium was approved for medical use in the European Union.[4] In June 2018, glycopyrronium was approved by the US Food and Drug Administration (FDA) to treat excessive underarm sweating, becoming the first drug developed specifically to reduce excessive sweating.[11] It is on the World Health Organization's List of Essential Medicines .[12]
Medical uses
Glycopyrronium was first used in 1961 to treat peptic ulcers . Since 1975, intravenous glycopyrronium has been used before surgery to reduce salivary , tracheobronchial , and pharyngeal secretions.[13] It is also used in conjunction with neostigmine , a neuromuscular blocking reversal agent , to prevent neostigmine's muscarinic effects such as bradycardia .[14] It can be administered to raise the heart rate in bradycardia , which often will also increase the blood pressure.
It is also used to reduce excessive saliva (sialorrhea ),[7] [15] [16] [17] and to treat Ménière's disease .[18]
It has been used topically and orally to treat hyperhidrosis , in particular, gustatory hyperhidrosis .[19] [20]
In inhalable form it is used to treat chronic obstructive pulmonary disease (COPD).[4] [5] [6] Doses for inhalation are much lower than oral ones, so that swallowing a dose will not have an effect.[21] [22]
Side effects
Dry mouth, urinary retention , headaches , vomiting , diarrhea , constipation , blurry vision are possible side effects of the medication.[13]
Pharmacology
Mechanism of action
Glycopyrronium competitively blocks muscarinic receptors ,[13] [23] thus inhibiting cholinergic transmission.
Pharmacokinetics
Glycopyrronium bromide affects the gastrointestinal tracts, liver and kidney but has a very limited effect on the brain and the central nervous system . In horse studies, after a single intravenous infusion, the observed tendencies of glycopyrronium followed a tri-exponential equation, by rapid disappearance from the blood followed by a prolonged terminal phase. Excretion was mainly in urine and in the form of an unchanged drug. Glycopyrronium has a relatively slow diffusion rate, and in a standard comparison to atropine , is more resistant to penetration through the blood-brain barrier and placenta .[24]
Research
It has been studied in asthma .[25] [26]
References
^ "Neurological therapies" . Health Canada . 9 May 2018. Retrieved 13 April 2024 .
^ a b "Robinul- glycopyrrolate tablet Robinul Forte- glycopyrrolate tablet" . DailyMed . 1 June 2021. Retrieved 20 June 2022 .
^ "Dartisla ODT- glycopyrrolate orally disintegrating tablets tablet, orally disintegrating" . DailyMed . 9 December 2021. Retrieved 20 June 2022 .
^ a b c d "Seebri Breezhaler EPAR" . European Medicines Agency (EMA) . 17 September 2018. Archived from the original on 29 February 2020. Retrieved 28 February 2020 .
^ a b c "Tovanor Breezhaler EPAR" . European Medicines Agency (EMA) . 17 September 2018. Archived from the original on 29 February 2020. Retrieved 28 February 2020 .
^ a b c "Enurev Breezhaler EPAR" . European Medicines Agency . 17 September 2018. Retrieved 29 January 2023 .
^ a b c d "Sialanar EPAR" . European Medicines Agency . 17 September 2018. Retrieved 29 January 2023 . Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
^ "Glycopyrrolate Oral Inhalation" . MedlinePlus . Archived from the original on 17 August 2021. Retrieved 20 June 2022 .
^ "Glycopyrronium Topical" . MedlinePlus . Archived from the original on 17 August 2021. Retrieved 20 June 2022 .
^ Bajaj V, Langtry JA (July 2007). "Use of oral glycopyrronium bromide in hyperhidrosis". The British Journal of Dermatology . 157 (1): 118–121. doi :10.1111/j.1365-2133.2007.07884.x . PMID 17459043 . S2CID 29080876 .
^ "FDA OKs first drug made to reduce excessive sweating" . AP News . Archived from the original on 2018-07-02. Retrieved 2018-07-02 .
^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021) . Geneva: World Health Organization. hdl :10665/345533 . WHO/MHP/HPS/EML/2021.02.
^ a b c Chabicovsky M, Winkler S, Soeberdt M, Kilic A, Masur C, Abels C (May 2019). "Pharmacology, toxicology and clinical safety of glycopyrrolate". Toxicology and Applied Pharmacology . 370 : 154–169. doi :10.1016/j.taap.2019.03.016 . PMID 30905688 . S2CID 85498396 .
^ Howard J, Wigley J, Rosen G, D'mello J (February 2017). "Glycopyrrolate: It's time to review". Journal of Clinical Anesthesia . 36 : 51–53. doi :10.1016/j.jclinane.2016.09.013 . PMID 28183573 .
^ Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M (December 2000). "Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study" . Archives of Pediatrics & Adolescent Medicine . 154 (12): 1214–1218. doi :10.1001/archpedi.154.12.1214 . PMID 11115305 . Archived from the original on 2011-08-10. Retrieved 2008-11-26 .
^ Tscheng DZ (November 2002). "Sialorrhea - therapeutic drug options". The Annals of Pharmacotherapy . 36 (11): 1785–1790. doi :10.1345/aph.1C019 . PMID 12398577 . S2CID 45799443 . [permanent dead link ]
^ Olsen AK, Sjøgren P (October 1999). "Oral glycopyrrolate alleviates drooling in a patient with tongue cancer" . Journal of Pain and Symptom Management . 18 (4): 300–302. doi :10.1016/S0885-3924(99)00080-9 . PMID 10534970 .
^ Maria SA, Claudia C, Pamela G, Andrea C, Roberto A (1 December 2012). "Medical therapy in Ménière's disease". Audiological Medicine . 10 (4): 171–177. doi :10.3109/1651386X.2012.718413 . S2CID 72380413 .
^ Kim WO, Kil HK, Yoon DM, Cho MJ (August 2003). "Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate" . Yonsei Medical Journal . 44 (4): 579–582. doi :10.3349/ymj.2003.44.4.579 . PMID 12950111 .
^ Kim WO, Kil HK, Yoon KB, Yoon DM (May 2008). "Topical glycopyrrolate for patients with facial hyperhidrosis". The British Journal of Dermatology . 158 (5): 1094–1097. doi :10.1111/j.1365-2133.2008.08476.x . PMID 18294315 . S2CID 39870296 .
^ "EPAR – Product information for Seebri Breezhaler" (PDF) . European Medicines Agency . 28 September 2012. Archived (PDF) from the original on 30 July 2018. Retrieved 4 February 2017 .
^ Tzelepis G, Komanapolli S, Tyler D, Vega D, Fulambarker A (January 1996). "Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease" . The European Respiratory Journal . 9 (1): 100–103. doi :10.1183/09031936.96.09010100 . PMID 8834341 .
^ Haddad EB, Patel H, Keeling JE, Yacoub MH, Barnes PJ, Belvisi MG (May 1999). "Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways" . British Journal of Pharmacology . 127 (2): 413–420. doi :10.1038/sj.bjp.0702573 . PMC 1566042 . PMID 10385241 .
^ Rumpler MJ, Colahan P, Sams RA (June 2014). "The pharmacokinetics of glycopyrrolate in Standardbred horses". Journal of Veterinary Pharmacology and Therapeutics . 37 (3): 260–268. doi :10.1111/jvp.12085 . PMID 24325462 .
^ Hansel TT, Neighbour H, Erin EM, Tan AJ, Tennant RC, Maus JG, Barnes PJ (October 2005). "Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma" . Chest . 128 (4): 1974–1979. doi :10.1378/chest.128.4.1974 . PMID 16236844 . Archived from the original on 2013-04-14.
^ Gilman MJ, Meyer L, Carter J, Slovis C (November 1990). "Comparison of aerosolized glycopyrrolate and metaproterenol in acute asthma" . Chest . 98 (5): 1095–1098. doi :10.1378/chest.98.5.1095 . PMID 2225951 . Archived from the original on 2013-04-14.
mAChRs Tooltip Muscarinic acetylcholine receptors
Agonists Antagonists
3-Quinuclidinyl benzilate
4-DAMP
Aclidinium bromide (+formoterol )
Abediterol
AF-DX 250
AF-DX 384
Ambutonium bromide
Anisodamine
Anisodine
Antihistamines (first-generation) (e.g., brompheniramine , buclizine , captodiame , chlorphenamine (chlorpheniramine) , cinnarizine , clemastine , cyproheptadine , dimenhydrinate , dimetindene , diphenhydramine , doxylamine , meclizine , mequitazine , perlapine , phenindamine , pheniramine , phenyltoloxamine , promethazine , propiomazine , triprolidine )
AQ-RA 741
Atropine
Atropine methonitrate
Atypical antipsychotics (e.g., clozapine , fluperlapine , olanzapine (+fluoxetine ), rilapine , quetiapine , tenilapine , zotepine )
Benactyzine
Benzatropine (benztropine)
Benzilone
Benzilylcholine mustard
Benzydamine
BIBN 99
Biperiden
Bornaprine
Camylofin
CAR-226,086
CAR-301,060
CAR-302,196
CAR-302,282
CAR-302,368
CAR-302,537
CAR-302,668
Caramiphen
Cimetropium bromide
Clidinium bromide
Cloperastine
CS-27349
Cyclobenzaprine
Cyclopentolate
Darifenacin
DAU-5884
Desfesoterodine
Dexetimide
DIBD
Dicycloverine (dicyclomine)
Dihexyverine
Difemerine
Diphemanil metilsulfate
Ditran
Drofenine
EA-3167
EA-3443
EA-3580
EA-3834
Emepronium bromide
Etanautine
Etybenzatropine (ethybenztropine)
Fenpiverinium
Fentonium bromide
Fesoterodine
Flavoxate
Glycopyrronium bromide (+beclometasone/formoterol , +indacaterol , +neostigmine )
Hexahydrodifenidol
Hexahydrosiladifenidol
Hexbutinol
Hexocyclium
Himbacine
HL-031,120
Homatropine
Imidafenacin
Ipratropium bromide (+salbutamol )
Isopropamide
J-104,129
Hyoscyamine
Mamba toxin 3
Mamba toxin 7
Mazaticol
Mebeverine
Meladrazine
Mepenzolate
Methantheline
Methoctramine
Methylatropine
Methylhomatropine
Methylscopolamine
Metixene
Muscarinic toxin 7
N-Ethyl-3-piperidyl benzilate
N-Methyl-3-piperidyl benzilate
Nefopam
Octatropine methylbromide (anisotropine methylbromide)
Orphenadrine
Otenzepad (AF-DX 116)
Otilonium bromide
Oxapium iodide
Oxitropium bromide
Oxybutynin
Oxyphencyclimine
Oxyphenonium bromide
PBID
PD-102,807
PD-0298029
Penthienate
Pethidine
pFHHSiD
Phenglutarimide
Phenyltoloxamine
Pipenzolate bromide
Piperidolate
Pirenzepine
Piroheptine
Pizotifen
Poldine
Pridinol
Prifinium bromide
Procyclidine
Profenamine (ethopropazine)
Propantheline bromide
Propiverine
Quinidine
3-Quinuclidinyl thiochromane-4-carboxylate
Revefenacin
Rociverine
RU-47,213
SCH-57,790
SCH-72,788
SCH-217,443
Scopolamine (hyoscine)
Scopolamine butylbromide (hyoscine butylbromide)
Silahexacyclium
Sofpironium bromide
Solifenacin
SSRIs Tooltip Selective serotonin reuptake inhibitors (e.g., femoxetine , paroxetine )
Telenzepine
Terodiline
Tetracyclic antidepressants (e.g., amoxapine , maprotiline , mianserin , mirtazapine )
Tiemonium iodide
Timepidium bromide
Tiotropium bromide
Tiquizium bromide
Tofenacin
Tolterodine
Tricyclic antidepressants (e.g., amitriptyline (+perphenazine ), amitriptylinoxide , butriptyline , cidoxepin , clomipramine , desipramine , desmethyldesipramine , dibenzepin , dosulepin (dothiepin) , doxepin , imipramine , lofepramine , nitroxazepine , northiaden (desmethyldosulepin) , nortriptyline , protriptyline , quinupramine , trimipramine )
Tridihexethyl
Trihexyphenidyl
Trimebutine
Tripitamine (tripitramine)
Tropacine
Tropatepine
Tropicamide
Trospium chloride
Typical antipsychotics (e.g., chlorpromazine , chlorprothixene , cyamemazine (cyamepromazine) , loxapine , mesoridazine , thioridazine )
Umeclidinium bromide (+vilanterol )
WIN-2299
Xanomeline
Zamifenacin
Precursors (and prodrugs )